TDI-6118

N/A

Report date: 2026/01/13 17:56:49
NME

Base Information

Drug NameTDI-6118
Drug Alias NameTDI-6118
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone-lysine N-methyltransferase EZH2 inhibitors
TargetsHistone-lysine N-methyltransferase EZH2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTri-Institutional Therapeutics Discovery Institute
China Registration ClassN/A

Develop Information

Active CompaniesTri-Institutional Therapeutics Discovery Institute
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A